Andrew Zolopa, MD

Head of North America Medical Affairs
ViiV Healthcare
Portola Valley, California, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1582 - Real-World Use of Long-Acting Cabotegravir + Rilpivirine in the US: Effectiveness in the First Year

  Friday, October 21, 2022
  3:15 PM – 3:30 PM US ET

• 2255 - Suppressed Switch to DTG/3TC 2-Drug Regimen Vs. BIC- or DTG-Based 3-Drug Regimens

  Saturday, October 22, 2022
  12:15 PM – 12:45 PM US ET